Statistical methods for the use of historical control data in testing for a trend in proportions in carcinogenicity rodent bioassays are reviewed. Asymptotic properties of the Hoel-Yanagawa exact conditional tests are developed and compared with the Tarone test. It is indicated that the Hoel-Yanagawa test is more powerful than the Tarone test. These tests depend on the beta-binomial parameters which are estimated from historical data. The goodness of fit of beta-binomial distributions to historical data is illustrated by application to the historical control database in the National Toxicology Program. Finally, sensitivities of the exact conditional test to the historical information is discussed and a conservative use of the test is considered.
Introduction
To begin, we consider Table 1 , which summarizes the data from an experiment involving r + 1 groups of animals. One group serves as a control group and the remaining r groups are administered a test compound at increasing dose levels, d1 < d2 < ... < dr. The control group is associated with i = 0 so that do = 0. Let ni denote'the number of animals in the i-th group. We assume for i = 0, 1, . . ., r that at experimental dose di there are xi animals with tumors observed which are binomially distributed with parameters pi and ni. We define p = po.
To test an increase in the proportions pi = xilni with increasing dose level, Cochran (1) and Armitage (2) Cox (3) showed that this statistic gives the uniformly most powerful unbiased test against logistic alternatives and Tarone and Gart (4) showed that this statistic is asymptotically locally optimum against any alternative which can be expressed as a smooth increasing function of dose.
In most carcinogenicity rodent bioassays, we are usually dealing with three experimental groups of animals which consist of a control group, a low dose and a high dose group each with 50 animals. The probability of an animal with a specific type of tumor in the control group ranges from less than 1% to 20% depending upon the type of tumor.
When the Cochran-Armitage test is applied to these bioassays, two problems arise: the problem of false positives (Type I error) and that of false negatives (Type II error). For the first problem, Portier and Hoel (5) showed that when the Cochran-Armitage test is used the false positives can be considerable, depending mark- Th(Ot4) = flx+da + 13n-d1
Since XO, X1, .. ., X,. are independent conditioned on p, the joint distribution of a and X = (XO, Xl, *.., Xr)
Thus the marginal distribution of X is ft(x) = 7 f(a,x)da
In particular, the marginal distribution of XO is
which is independent of t.
Unconditional Tests
The locally most powerful test (12) for Ho: = 0 vs.
H1: e > 0 is given by
After some simple calculation we find that r(n + a + r)
( The above results show that Tarone's standardization is the best among the three, although the standardization is not easy to justify. It is shown in Hoel and Yanagawa (7) that when 0 is small, n must be quite large for the normality of the asymptotic tests to be a reasonable approximation.
Exact Conditional Test
Since fo(x) is independent of i, we have that XO is an ancillary statistic. Fisher (14) suggested that for purposes of inference on should consider the family of conditional distributions given the observed value of the ancillary statistic in the sample. Denote byft(xlxO) the conditional probability density function of X given XO = XO. The conditional locally most powerful test for Ho: (=0 vs. H1: t>0 is given by
and it is easy to show that T is given by Eq. (1).
In general, let to be the observed value of T; then the exact p-value of the conditional test is given by p-value = E, (niA Rx + a)F(n + -x)F(no + a +) ik= i X (xo + ot)F(no + 1o -x)F(n + a + 1 where the summation ' extends over all (x1,x2, xr), which satisfy T < to for given XO = xo. For the NTP data with r = 2, no = n1 = n2 = 50 and p ranging from 1% to 20%, computations of the p-value by computer is very quick.
Asymptotic Properties of the Exact Conditional Tests
Hoel and Yanagawa (7) Following the development in Hoel and Yanagawa (7) one may show that: (1) 
Historical Control Database
Problems encountered in the historical control data are discussed by Haseman, Huff, and Boorman (11) . Examining the NCI/NTP historical data carefully, these authors find that different terminologies are often used to describe the same tumor even for studies at the same laboratory carried out at approximately the same time. Also the use of different sets of criteria for diagnosing a lesion is revealed. Discussing the criteria that will aid in determining whether a particular study should be included in the database, Haseman, Huff, and Boorman (11) state "Certainly species, strain, sex, study duration, pathology protocols, nomenclature conventions, quality assurance and review procedures should be the same for each study in a particular control database. Ideally, diets, changing regiments, and various environmental parameters should also be comparable. Different types of control groups (e.g., untreated, corn oil gavage) should be dealt with separately. Other potential sources of variability (calendar year, laboratory, pathologist, supplier) should also be investigated, identified and controlled." The current database thus established in the NTP contains information beginning with those studies reported in Technical Report 193, 1981 through those studies whose pathology diagnoses were finalized in Carcinogenesis Bioassay Data System as of March, 1983 . Most control groups have 50 animals/species/sex and all are from studies of two years duration. About 50 control groups/species/sex are contained in the database.
We fitted beta-binomial distribution to the data for each tumor type in the database. Table 3 shows for selected tumor sites in the Fisher 344 rat the estimates of the beta-binomial parameters a and 13, a + 1, and o = a/(a + 1), and their standard deviations. These es- The exact conditional tests developed in the preceding these confidence intervals (see the shaded area in Figure  sections depend on beta-binomial parameters, a and ,B, 1). They found numerically that these maxima and minwhich are estimated from historical control data. As ima seem to be attained always at the four corner points, i.e., A, B, C, and D in Figure 1 . Table 4 shows p-values at A, B, C, and D, and at the point 0 of estimated a and S3 for several configurations of (x0,x1,x2) for tumors of the thyroid and tumors of the hematopoietic system using as usual n0 = =1-n = 50.
Conservative Use of the Conditional Test
The inspection of Table 4 leads to the following conservative rule for incorporating historical control data by the exact conditional test for testing positive doseresponse:
(Ri) Compute p-values at the five points A, B, C, D, and 0.
(R2) Do not attempt to draw any inference when the maximum p-value of these five points exceeds the nominal level, e.g., 0.01 or 0.05.
This rule is very conservative, but it still works well in practice, especially for tumors with small spontaneous background rates. This is shown by comparing the maximum p-value with the p-value of the exact trend test (1,2,3) .
